4 Stocks Dragging In The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 20 points (0.1%) at 14,984 as of Friday, Aug. 23, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,794 issues advancing vs. 1,149 declining with 104 unchanged.

The Health Services industry currently sits up 0.1% versus the S&P 500, which is up 0.2%.

TheStreet would like to highlight 4 stocks pushing the industry lower today:

4. Mettler-Toledo International ( MTD) is one of the companies pushing the Health Services industry lower today. As of noon trading, Mettler-Toledo International is down $2.34 (-1.0%) to $227.91 on light volume. Thus far, 15,071 shares of Mettler-Toledo International exchanged hands as compared to its average daily volume of 143,100 shares. The stock has ranged in price between $226.77-$231.55 after having opened the day at $231.52 as compared to the previous trading day's close of $230.25.

Mettler-Toledo International Inc. supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. Mettler-Toledo International has a market cap of $6.8 billion and is part of the health care sector. Shares are up 15.6% year to date as of the close of trading on Thursday. Currently there are 3 analysts that rate Mettler-Toledo International a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Mettler-Toledo International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Stryker Corporation ( SYK) is down $0.47 (-0.7%) to $68.31 on light volume. Thus far, 290,608 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $68.17-$68.91 after having opened the day at $68.74 as compared to the previous trading day's close of $68.78.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $25.7 billion and is part of the health care sector. Shares are up 25.5% year to date as of the close of trading on Thursday. Currently there are 14 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 12 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Agilent Technologies ( A) is down $0.23 (-0.5%) to $47.74 on light volume. Thus far, 857,658 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $47.54-$48.00 after having opened the day at $47.99 as compared to the previous trading day's close of $47.97.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $16.2 billion and is part of the health care sector. Shares are up 17.1% year to date as of the close of trading on Thursday. Currently there are 13 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, expanding profit margins, increase in stock price during the past year, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agilent Technologies Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Medtronic ( MDT) is down $0.56 (-1.1%) to $52.80 on average volume. Thus far, 3.2 million shares of Medtronic exchanged hands as compared to its average daily volume of 5.1 million shares. The stock has ranged in price between $52.73-$53.72 after having opened the day at $53.34 as compared to the previous trading day's close of $53.36.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $53.1 billion and is part of the health care sector. Shares are up 28.4% year to date as of the close of trading on Thursday. Currently there are 6 analysts that rate Medtronic a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, attractive valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Medtronic Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Video: Stop Using Student Loan Money to Buy Bitcoin

Video: Stop Using Student Loan Money to Buy Bitcoin

Let the Najarian Brothers Crash-Proof Portfolio

Let the Najarian Brothers Crash-Proof Portfolio

Facebook Sends Facial Recognition Notification in Error

Facebook Sends Facial Recognition Notification in Error